March 20, 2024MoleculesOpen Access

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

View Full Paper

Ask AI

Bookmark

Authors

WTWamidh H. TalibApplied Science Private University DADima AwajanApplied Science Private University AAAbdelrahim AlqudahQueen's University Belfast

Discussion

Member takes

Implication

Review demonstrates that epigallocatechin gallate disrupts cancer hallmarks in cell lines and animal models, highlighting its therapeutic potential as an anticancer treatment.

Key Points

Epigallocatechin gallate suppresses cancer hallmarks across diverse malignancies, inducing pro-apoptotic responses and halting cellular proliferation in experimental tumor systems.
Review of published literature demonstrates that the green tea catechin EGCG interrupts critical signaling pathways across diverse cancer cell lines and animal models.
Highlights the therapeutic potential of the flavonoid EGCG as an anticancer treatment, though findings remain restricted to animal models and require future clinical investigation.

Cite This Study

Talib et al. (2024) studied this question.

synapsesocial.com/papers/68e732b8b6db6435876aba60 https://doi.org/10.3390/molecules29061373

View Full Paper

Ask AI

Bookmark

Implication

Review demonstrates that epigallocatechin gallate disrupts cancer hallmarks in cell lines and animal models, highlighting its therapeutic potential as an anticancer treatment.

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

Discussion

Member takes

Implication

Key Points

Cite This Study

Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider